JAKARTA (Reuters) – The Indonesian food and drug agency (BPOM) said it would announce the results from the clinical trials of Sinovac’s COVID-19 vaccine, CoronaVac, later on Monday.
Indonesia is set to begin its vaccination campaign using CoronaVac on Wednesday but first requires emergency authorisation approval from BPOM. Indonesia has received 3 million doses of CoronaVac and is set to receive some 122.5 million more.
(Reporting by Stanley Widianto; Editing by Martin Petty)
